Multislice computed tomography angiography for noninvasive assessment of the 18-month performance of a novel radiolucent bioresorbable vascular scaffolding device: the ABSORB trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)

J Am Coll Cardiol. 2013 Nov 5;62(19):1813-4. doi: 10.1016/j.jacc.2013.07.030. Epub 2013 Aug 7.

Authors

Koen Nieman¹, Patrick W Serruys, Yoshinobu Onuma, Robert-Jan van Geuns, Hector M Garcia-Garcia, Bernard de Bruyne, Leif Thuesen, Pieter C Smits, Jacques J Koolen, Dougal McClean, Bernard Chevalier, Ian Meredith, John Ormiston

Affiliation

¹ Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Radiology, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: koennieman@hotmail.com.

PMID: 23933536
DOI: 10.1016/j.jacc.2013.07.030

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Absorbable Implants*
Coronary Angiography
Coronary Artery Disease / diagnostic imaging*
Coronary Artery Disease / surgery
Drug-Eluting Stents*
Everolimus
Follow-Up Studies
Humans
Immunosuppressive Agents / pharmacology
Multidetector Computed Tomography / methods*
Myocardial Revascularization / methods*
Prosthesis Design
Randomized Controlled Trials as Topic
Sirolimus / analogs & derivatives*
Sirolimus / pharmacology

Substances

Immunosuppressive Agents
Everolimus
Sirolimus